Chromogranin A as a Biochemical Marker for Neuroendocrine Tumors: A Single Center Experience at Royal Hospital, Oman

OBJECTIVES: To evaluate the significance of serum chromogranin A (CgA) status in patients with and without different neuroendocrine tumors (NETs) by conducting a retrospective assessment of the diagnostic utility and limitations of CgA as a biomarker for NETs in a tertiary care hospital in Oman. MET...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oman Med J
Prif Awduron: Al-Risi, Elham S., Al-Essry, Fatma S., Mula-Abed, Waad-Allah S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: OMJ 2017
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632692/
https://ncbi.nlm.nih.gov/pubmed/29026467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2017.71
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg